| pubmed-article:10474477 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C0554011 | lld:lifeskim |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C0038994 | lld:lifeskim |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C0040555 | lld:lifeskim |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C0162473 | lld:lifeskim |
| pubmed-article:10474477 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:10474477 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10474477 | pubmed:dateCreated | 1999-9-17 | lld:pubmed |
| pubmed-article:10474477 | pubmed:abstractText | Botulinum toxin has been successfully used to treat Frey's syndrome occurring in a 31-year-old patient following superficial parotidectomy for pleomorphic adenoma. An initial injection of 7.5 U (0.3 ml over 6 cm2 of cheek) resulted in 3 months' resolution of gustatory sweating and flushing and a second injection 12 months' symptomatic improvement. The symptoms recurred after further facial surgery. | lld:pubmed |
| pubmed-article:10474477 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10474477 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10474477 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10474477 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10474477 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10474477 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10474477 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10474477 | pubmed:issn | 0007-1226 | lld:pubmed |
| pubmed-article:10474477 | pubmed:author | pubmed-author:VarmaS KSK | lld:pubmed |
| pubmed-article:10474477 | pubmed:author | pubmed-author:NarulaA AAA | lld:pubmed |
| pubmed-article:10474477 | pubmed:author | pubmed-author:BirchJ FJF | lld:pubmed |
| pubmed-article:10474477 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10474477 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:10474477 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10474477 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10474477 | pubmed:pagination | 230-1 | lld:pubmed |
| pubmed-article:10474477 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:meshHeading | pubmed-meshheading:10474477... | lld:pubmed |
| pubmed-article:10474477 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10474477 | pubmed:articleTitle | Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy. | lld:pubmed |
| pubmed-article:10474477 | pubmed:affiliation | Department of Plastic Surgery, Leicester Royal Infirmary, UK. | lld:pubmed |
| pubmed-article:10474477 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10474477 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:10474477 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
